menu
    • menu

    Company profile for Xcovery

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We solve for x, where x is “working toward agents that are more aggressive toward cancers but more compassionate toward people.”Every day, we are not just inspired, we are called to build a pipeline of oncology medicines that better treat advanced malignant tumors while being less toxic for the patients who need them. In liaison with our global partners, we strive to design small-molecule targeted oncology therapies that n...
    We solve for x, where x is “working toward agents that are more aggressive toward cancers but more compassionate toward people.”Every day, we are not just inspired, we are called to build a pipeline of oncology medicines that better treat advanced malignant tumors while being less toxic for the patients who need them. In liaison with our global partners, we strive to design small-molecule targeted oncology therapies that not only work better and more safely but also eliminate the challenges associated with cancer-treatment resistance.At Xcovery, our mission is simple: to employ advanced science to create leading-edge oncology therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XcoveryUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1170 U.S. Hwy One, Suite 202 Palm Beach Gardens, FL 33408
    Telephone
    Telephone
    (561) 835-9356
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://xcovery.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/xcovery
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/xcovery?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Approval of Ensartinib for ALK-Positive NSCLC
    FDA Approval of Ensartinib for ALK-Positive NSCLC

    19 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241218355621/en

    BUSINESSWIRE
    19 Dec 2024
    Share Share
    FDA Has Accepted the New Drug Application (NDA) for Ensartinib
    FDA Has Accepted the New Drug Application (NDA) for Ensartinib

    13 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240313675039/en

    BUSINESSWIRE
    13 Mar 2024
    Share Share
    Xcovery SHP2 Inhibitor IND Approved by US FDA
    Xcovery SHP2 Inhibitor IND Approved by US FDA

    23 May 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/xcovery-shp2-inhibitor-ind-approved-by-us-fda/

    BIOSPACE
    23 May 2022
    Share Share
    Xcovery Acquires Majority Controlling Stake in Meryx Pharmaceuticals
    Xcovery Acquires Majority Controlling Stake in Meryx Pharmaceuticals

    07 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211207005432/en

    BUSINESSWIRE
    07 Dec 2021
    Share Share
    Xcovery Announces the Appointment of Giovanni Selvaggi as CEO
    Xcovery Announces the Appointment of Giovanni Selvaggi as CEO

    18 Mar 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210318005884/en

    BUSINESSWIRE
    18 Mar 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search